dipyridamole and cangrelor

dipyridamole has been researched along with cangrelor in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bath, P; Heptinstall, S; Zhao, L1
Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L1
Grieco, G; Jonas, S1

Reviews

1 review(s) available for dipyridamole and cangrelor

ArticleYear
Potential value of triple antiplatelet therapy for secondary stroke prevention.
    Stroke, 2003, Volume: 34, Issue:10

    Topics: Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Treatment Outcome

2003

Other Studies

2 other study(ies) available for dipyridamole and cangrelor

ArticleYear
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Communication; Dipyridamole; Drug Synergism; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Monocytes; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors

2001
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
    Current medical research and opinion, 2003, Volume: 19, Issue:3

    Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin

2003